As part of the Ministry of Health's efforts to boost the immunity of groups of the population that are most vulnerable to serious disease, the Council of Ministers at its meeting today decided:
a) the administration of a booster/3rd dose of vaccine, to persons aged 12 years and older with MRNA technology vaccine (Pfizer), provided that the period of six (6) months from the receipt of the 2nd dose has elapsed.
the administration of a booster/4th dose of vaccine:
- to persons over 70 years of age, provided that a period of five (5) months has elapsed since the receipt of the booster/3rd dose, [*]to persons of any age, residing or working in nursing homes and closed institutions, health professionals and immunosuppressed persons*, provided that a period of five (5) months has elapsed since receiving the booster/3rd dose.
*Immunosuppressed individuals:
- On active treatment for solid tumors and hematologic malignancies
- With a history of solid organ transplantation receiving immunosuppressive therapy
- With a history of primary hematopoietic organ transplantation receiving immunosuppressive therapy
- Subjects with hereditary immunodeficiency
- Subjects with HIVInfection/AIDS
- Subjects on immunosuppressive therapy including biological agents
- Regarding cortisone, refers to subjects who have received or are receiving a total dose of '10 mg of prednisone/day (=8 mg of methylprednisolone) for one (1) month in the last six months.
- With renal failure undergoing dialysis or peritoneal dialysis.
Receiving the booster (3rd or 4th) dose of vaccine is optional.
The start date of vaccination and the procedure to be followed will be announced at a later stage.
(MB)
Contents of this article including associated images are owned by PIO
Views & opinions expressed are those of the author and/or PIO
Source
